Treatment of Kaposi's sarcoma

Archives of Dermatology

Volumn 132, Issue 3, 1996, Pages 327-331

  Tur, Ethel ^a   Brenner, Sarah ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; APOLIPOPROTEIN E3; BLEOMYCIN; CHORIONIC GONADOTROPIN; CYTOKINE; DACARBAZINE; DACTINOMYCIN; DIMETHYL SULFOXIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FUMAGILLOL CHLOROACETYLCARBAMATE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROCORTISONE ACETATE; INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; NADROPARIN; ONCOSTATIN M; PACLITAXEL; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; RETINOIC ACID; SCLEROSING AGENT; TENIPOSIDE; THROMBOCYTE FACTOR 4; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; ZIDOVUDINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG TARGETING; FEVER; HUMAN; INFLUENZA; INJECTION PAIN; INTRALESIONAL DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; LASER SURGERY; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; RIGOR; SKIN DISCOLORATION; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CRYOSURGERY; HUMANS; LASER SURGERY; RADIOTHERAPY DOSAGE; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 0029916797     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.132.3.327     Document Type: Review

References (57)

1. Kaposi M. Idiopathisches multiples Pigmentsarkom der Haut. Arch Dermatol Syphilol. 1872; 4:265-273.
2. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma Science. 1994; 266:1865-1869.
3. Krown SE, Myskowski PL, Paredes J Kaposi's sarcoma. Med Clin North Am 1992,76:235-252.
4. Martin RW, Hood AF, Farmer ER Kaposi's sarcoma. Medicine 1993;72:245-261.
5. Monfardini S, Tirelli U, Vaccher E. Treatment of acquired immunodeficiency syndrome (AIDS)-related cancer. Cancer Treat Rev. 1994:20:149-172.
6. Northfelt DW. Treatment of Kaposi's sarcoma current guidelines and future perspectives. Drugs. 1994;48:569-582.
7. Epstein JB. Treatment of oral Kaposi's sarcoma with intralesional vinblastine. Cancer 1993,71: 1722-1725.
8. Poignonec S, Laehiver LD, Lamas G, Coutellier A, Caumes E, Soudant J. Intralesional bleomycin for acquired immunodeficiency syndrome-associated cutaneous Kaposi's sarcoma. Arch Dermatol. 1995;131.228.
9. Lucatorto FM, Sapp JP. Treatment of oral Kaposi's sarcoma with a sclerosing agent in AIDS patients. Oral Surg Oral Med Oral Pathol. 1993; 75:192-198.
10. Muzyka BC, Glick M. Sclerotherapy for the treatment of nodular intraoral Kaposi's sarcoma in patients with AIDS N Engl J Med 1993,328: 210-211.
11. Trattner A, Reizis Z, David M, Ingber A, Hagler J, Sandbank M. The therapeutic effect of intralesional Interferon in classical Kaposi's sarcoma. Br J Dermatol. 1993;129:590-593.
12. Alecu M, Ghyka G, Halalau F, Calugaru A, Coman G. Intralesional human leucocyte interferon treatment in the non-AIDS related Kaposi's sarcoma. Rev Roum Med Intern. 1990,28: 61-67
13. Ghyka G, Alecu M, Halalau F, Coman G. Intralesional human leucocyte interferon treatment alone or associated with IL-2 in non-AIDS related Kaposi's sarcoma. J Dermatol. 1992;19:35-39
14. Dupuy J, Price M, Lynch G, Bruce S, Schwartz M. Intralesional interferon-α and zidovudine in epidemic Kaposi's sarcoma. J Am Acad Dermatol. 1993;28:966-972.
15. Sulis E, Floris C, Sullis ML, et al. Interferon administered intralesionally in skin and oral cavity lesions in heterosexual drug addicted patients with AIDS-related Kaposi's sarcoma. Eur J Cancer Clin Oncol. 1983;25:759-769.
16. Tur E, Brenner S. Low dose recombinant interferon alfa treatment for classic Kaposi's sarcoma Arch Dermatol. 1994;130:800-801
17. Costa da Cunha CS, Lebbé C, Rybojad M, et al Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa 2b. Arch Dermatol. 1996;132:285-290.
18. Boente P, Sampaio C, Brandao MA, Moreira ED, Badaro R, Jones TC. Local perilesional therapy with rhGM-CSF for Kaposi's sarcoma Lancet. 1993;341:1154.
19. Bonhomme L, Fredj G, Averous S, et al. Topical treatment of epidemic Kaposi's sarcoma with all-trans-retinoic acid. Ann Oncol. 1991;2 234-235
20. Bonnetblanc JM, Weinbreck P, Lachatre G. Bedane C. Topical bleomycin-dimethyl sulfoxide in AIDS Kaposi's sarcoma. Acta Derm Venereol. 1994;74:330-331.
21. De Soccaraz C, de Soccaraz H. Local treatment of Kaposi's sarcoma in AIDS patients Dermatology. 1993;187:78
22. Smith KJ, Konzelman JL, Lombarde FA, et al. Iontophoresis of vinblastine into normal skin and for treatment of Kaposi's sarcoma in human immunodeficiency virus-positive patients. Arch Dermatol. 1992,128 1365-1370.
23. Piccinno R, Caccialanza M, Cusini M. Role of radiotherapy in the treatment of epidemic Kaposi's sarcoma: experience with sixty-five cases. J Am Acad Dermatol 1995;32:1000-1003
24. Piedbois P, Frikha H, Martin L, Levy E, Haddad E, Le-Bourgeois JP. Radiotherapy in the management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys. 1994;30:1207-1211.
25. Webster GF. Local therapy for mucocutaneaus Kaposi's sarcoma in patients with acquired immunodeficiency syndrome Dermatol Surg 1995; 21.205-208.
26. Tur E, Brenner S, Michalevicz R. Low dose recombinant interferon alfa treatment for classic Kaposi's sarcoma Arch Dermatol. 1993, 129: 1297-1300.
27. Busso M, Berman B. Antivirals m dermatology. J Am Acad Dermatol. 1995;32:1031-1040
28. Chimenti S, Peris K, Di Cristofaro S, Fargnoli MC, Torlone G. Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma Dermatology. 1995;190:214-217.
29. Blank B, Dewit R. Treatment of Kaposi's sarcoma with interferon-alpha and other biological response modifiers. Clin Immunother 1994;2: 443-457.
30. Carmeli Y, Mevorach D, Kaminski N, Raz E. Regression of Kaposi's sarcoma after intravenous immunoglobulin treatment for polymyositis. Cancer. 1994;73:2859-2861.
31. Alonso K, Pontiggia P, Nardi C, Sabato A, Curto FC. Systemic hyperthermia in the treatment of HIV-related Kaposi's sarcoma: a phase I study. Biomed Pharmacother. 1992,46 21-24.
32. Brambilla L, Labianca R, Boneschi V, et al. Mediterranean Kaposi's sarcoma in the elderly: a randomized study of oral etoposide versus vinblastine. Cancer. 1994;74.2873-2878
33. Gill PS, Miles SA, Mitsuyasu RT. Phase I AIDS clinical trials group (075) study of Adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma. AIDS. 1994;8:1695-1699.
34. Bakker PJ, Danner SA, ten-Napel CH, et al. Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant granulocyte-monocyte colony-stimulating factor (rh GM-CSF). Eur J Cancer 1995;31A:188-192.
35. Hengge UR, Brockmeyer NH, Baumann M, Reimann G, Goos M. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma. Lancet 1993; 342.496
36. Presant CA, Scolaro M, Kennedy P, et al. Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma. Lancet. 1993;341: 1242-1243.
37. Bogner JR, Kronawitter U, Rolinski B, Truebenach K, Goebel FD. Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi's sarcoma J Acquir Immune Defic Syndr 1994;7: 463-468
38. Presant CA, Scolaro M, Kennedy P, et al. Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma Lancet. 1993;341: 1242-1243
39. Gill PS, Espina BM, Muggia F, et al Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol. 1995;13:996-1003.
40. Harrison M, Tomlinson D, Stewart S. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma. J Clin Oncol. 1995; 13:914-920.
41. Saville MW, Lietzau J, Pluda JM, et al. Use of paclitaxel (Taxol) as therapy for HIV-associated Kaposi's sarcoma. AIDS Weekly. 1995;2:22.
42. Pluda JM, Shay LE, Foli A. Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma J Natl Cancer Inst. 1993;85:1585-1592.
43. Gill PS, Espina BM, Moudgil T, et al All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study. Leukemia. 1994;8(suppl 3).S26-S32.
44. Klimas N, Patarca R, Walling J, et al. Clinical and immunological changes in AIDS patients following adoptive therapy with activated autologous CD8 T cells and interleukin-2 infusion. AIDS. 1994; 8:1073-1081
45. Guo WX, Gill PS, Antakly T. Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation Cancer Res 1995; 55:823-829.
46. Corbeil J, Rapaport E, Richman D, Badel P, Looney DJ. Inhibition and killing of Kaposi's sarcoma cells by retinoids. Cancer Biotechnol Weekly. February 20, 1995.22
47. Lunardi-Iskandar Y, Bryant JL, Zeman RA, et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature. 1995;375.64-68.
48. Browning PJ, Roberts DD, Zabrenetzky V, et al. Apolipoprotein E (ApoE), a novel heparin-binding protein inhibits the development of Kaposi's sarcoma-like lesions in BALB/c nu/nu mice. J Exp Med. 1994;180.1949-1954
49. Ensoli B, Markman P, Kao V, et al. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor: a novel strategy for the therapy of KS. J Clin Invest. 1994;94: 1736-1746.
50. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med. 1995;332.1181-1185.
51. Ambroziak JA, Blackbourn DJ, Herndier BG, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science. 1995, 268:582-583
52. Su IJ, Hsu YS, Chang YC, Wang IW Herpesvirus-like DNA sequence in Kaposi's sarcoma from AIDS and non-AIDS patients in Taiwan Lancet 1995, 345:722-723
53. Huang YQ, Li JJ, Kaplan MH Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma Lancet. 1995;345:759-761.
54. Dupin N, Grandadam M, Calvez V, et al. Herpes-virus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma Lancet. 1995;345: 761-762
55. Roizman B. New viral footprints in Kaposi's sarcoma. N Engl J Med. 1995;332:1227-1228.
56. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995; 332 1186-1191.
57. Jones JL, Hanson DL, Chu SY, Ward JW, Jaffe HW. AIDS-associated Kaposi's sarcoma. Science. 1995;267:1078-1080.